| Literature DB >> 27636874 |
Abstract
There is evidence to support a link between treatment with high-dose cyproterone acetate and the development of meningioma. This report describes a case where an elderly man with intellectual disability who was treated with cyproterone for problematic sexual behavior developed a meningioma. The case was the subject of a residential medication management review provided under the auspices of a program funded by the Commonwealth Government of Australia. A discussion of clinical and ethical implications of the case is provided.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27636874 DOI: 10.4140/TCP.n.2016.500
Source DB: PubMed Journal: Consult Pharm ISSN: 0888-5109